ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Postdoctoral Scientist – Enzymatic Ligation Modeling at Eli Lilly and Company - ApplyBlast

Postdoctoral Scientist – Enzymatic Ligation Modeling

Eli Lilly and Company

3 months ago

4.0 on Glassdoor

Boston, Massachusetts, United States

Onsite

Full Time

Trainee

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

The postdoctoral role at Lilly Research Laboratories focuses on building predictive mechanistic models of enzymatic ligation kinetics to accelerate process development for oligonucleotide therapeutics. The scientist will leverage high‑throughput experimentation and computational tools to generate quantitative process understanding and collaborate across discovery and development teams in Boston and Indianapolis.

Responsibilities

Build predictive mechanistic models of enzymatic ligation kinetics
Generate quantitative process understanding for oligonucleotide assembly
Collaborate with multidisciplinary teams across Lilly sites
Publish research findings and present at scientific conferences
Develop computational workflows to accelerate process optimization

Skills

Qualifications

PhD in Chemical EngineeringPhD in ChemistryPhD in a related field

About Eli Lilly and Company

lilly.com

Headquarters

Indianapolis, Indiana, United States

Company Size

10001+ employees

Founded

1876

View Profile

Eli Lilly and Company is a global biopharmaceutical company headquartered in Indianapolis, Indiana. It discovers, develops, manufactures and commercializes prescription medicines across therapeutic areas including diabetes, oncology, immunology, neuroscience and pain, and has a longstanding history in insulin and other major drug discoveries. Lilly invests heavily in research and clinical development and partners with biotech, academic institutions, and industry collaborators to advance biologics, small molecules, and precision medicines. The company operates global manufacturing and commercial networks and provides patient-support programs to improve access to its therapies.